ClinicalTrialsFinder

Primary Graft Dysfunction Clinical Trials in San Francisco, California

1 recruitingSan Francisco, California

Showing 1–1 of 1 trials

Recruiting
Phase 2

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Acute Lung Injury(ALI)Natural Killer Cell Mediated ImmunityPrimary Graft Dysfunction+1 more
University of California, San Francisco120 enrolled1 locationNCT06853223